Protara Therapeutics (TARA) Revenue & Revenue Breakdown
Protara Therapeutics Revenue Highlights
Protara Therapeutics Revenue by Period
Protara Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | -100.00% |
2014-12-31 | $2.95M | - |
Protara Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.21M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | - |
Protara Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
VACC | Barinthus Biotherapeutics | $44.70M | - |
SQZ | SQZ Bio | $21.03M | - |
IKNA | Ikena Oncology | $9.16M | - |
LYRA | Lyra Therapeutics | $1.56M | $598.00K |
VCNX | Vaccinex | $570.00K | $232.00K |
MGTA | Dianthus Therapeutics | $314.00K | $72.00K |
TARA | Protara Therapeutics | - | - |
MTCR | Metacrine | - | - |
TRVI | Trevi Therapeutics | - | - |
MNPR | Monopar Therapeutics | - | - |
SRZN | Surrozen | - | - |
SRRK | Scholar Rock | - | - |
XLO | Xilio Therapeutics | - | $2.36M |
TARA Revenue FAQ
What is Protara Therapeutics’s yearly revenue?
Protara Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TARA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Protara Therapeutics’s quarterly revenue?
Protara Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TARA's quarterly revenue for Q4 2023 was $1.21M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Protara Therapeutics’s revenue growth rate?
Protara Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.